210 related articles for article (PubMed ID: 28420072)
21. Differential reactive oxygen species production of neutrophils and their oxidative damage in patients with active and inactive systemic lupus erythematosus.
Elloumi N; Ben Mansour R; Marzouk S; Mseddi M; Fakhfakh R; Gargouri B; Masmoudi H; Lassoued S
Immunol Lett; 2017 Apr; 184():1-6. PubMed ID: 28163154
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of P-glycoprotein and persistence of disease activity despite treatment in patients with systemic lupus erythematosus.
Perez-Guerrero EE; Gamez-Nava JI; Muñoz-Valle JF; Cardona-Muñoz EG; Bonilla-Lara D; Fajardo-Robledo NS; Nava-Zavala AH; Garcia-Cobian TA; Rincón-Sánchez AR; Murillo-Vazquez JD; Cardona-Müller D; Vazquez-Villegas ML; Totsuka-Sutto SE; Gonzalez-Lopez L
Clin Exp Med; 2018 Feb; 18(1):109-117. PubMed ID: 28243944
[TBL] [Abstract][Full Text] [Related]
23. Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus.
Mora C; Medina-Rosas J; Santos AM; Jaimes DA; Arbeláez AM; Romero C; Cortes A; Londono J
J Rheumatol; 2016 Sep; 43(9):1657-64. PubMed ID: 27134246
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus.
Smith CK; Vivekanandan-Giri A; Tang C; Knight JS; Mathew A; Padilla RL; Gillespie BW; Carmona-Rivera C; Liu X; Subramanian V; Hasni S; Thompson PR; Heinecke JW; Saran R; Pennathur S; Kaplan MJ
Arthritis Rheumatol; 2014 Sep; 66(9):2532-2544. PubMed ID: 24838349
[TBL] [Abstract][Full Text] [Related]
25. Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation.
Venturini D; Simão AN; Dichi I
Nutr Res; 2015 Sep; 35(9):759-65. PubMed ID: 26255193
[TBL] [Abstract][Full Text] [Related]
26. Effects of melatonin supplementation on serum oxidative stress markers and disease activity in systemic lupus erythematosus patients: A randomised, double-blind, placebo-controlled trial.
Nabatian-Asl M; Ghorbanihaghjo A; Malek Mahdavi A; Khabbazi A; Hajialilo M; Ghojazadeh M
Int J Clin Pract; 2021 Jul; 75(7):e14246. PubMed ID: 33877728
[TBL] [Abstract][Full Text] [Related]
27. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
[TBL] [Abstract][Full Text] [Related]
28. Immunological studies of reactive oxygen species damaged catalase in patients with systemic lupus erythematosus: correlation with disease activity index.
Al-Shobaili HA; Al Robaee AA; Alzolibani AA; Rasheed Z
Immunol Invest; 2013; 42(3):191-203. PubMed ID: 23461612
[TBL] [Abstract][Full Text] [Related]
29. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis.
Oates JC; Shaftman SR; Self SE; Gilkeson GS
Arthritis Rheum; 2008 Jan; 58(1):263-72. PubMed ID: 18163495
[TBL] [Abstract][Full Text] [Related]
30. Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder.
Maes M; Landucci Bonifacio K; Morelli NR; Vargas HO; Barbosa DS; Carvalho AF; Nunes SOV
Mol Neurobiol; 2019 Jan; 56(1):141-156. PubMed ID: 29681025
[TBL] [Abstract][Full Text] [Related]
31. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
[TBL] [Abstract][Full Text] [Related]
32. Correlation of serum measures of nitric oxide production with lupus disease activity.
Gilkeson G; Cannon C; Oates J; Reilly C; Goldman D; Petri M
J Rheumatol; 1999 Feb; 26(2):318-24. PubMed ID: 9972965
[TBL] [Abstract][Full Text] [Related]
33. Physicochemical and immunological studies on mitochondrial DNA modified by peroxynitrite: implications of neo-epitopes of mitochondrial DNA in the etiopathogenesis of systemic lupus erythematosus.
Al-Shobaili HA; Rasheed Z
Lupus; 2013 Sep; 22(10):1024-37. PubMed ID: 23884988
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity.
Hassan SZ; Gheita TA; Kenawy SA; Fahim AT; El-Sorougy IM; Abdou MS
Int J Rheum Dis; 2011 Oct; 14(4):325-31. PubMed ID: 22004228
[TBL] [Abstract][Full Text] [Related]
35. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients.
Morgan PE; Sturgess AD; Davies MJ
Free Radic Res; 2009 Feb; 43(2):117-27. PubMed ID: 19096973
[TBL] [Abstract][Full Text] [Related]
36. Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial.
Mok CC; Ying SK; Ma KM; Wong CK
Lupus; 2013 Dec; 22(14):1470-8. PubMed ID: 24113197
[TBL] [Abstract][Full Text] [Related]
37. Oxidative protein damage and antioxidant status in systemic lupus erythematosus.
Zhang Q; Ye DQ; Chen GP; Zheng Y
Clin Exp Dermatol; 2010 Apr; 35(3):287-94. PubMed ID: 19874339
[TBL] [Abstract][Full Text] [Related]
38. Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus.
Peschken CA; Wang Y; Abrahamowicz M; Pope J; Silverman E; Sayani A; Iczkovitz S; Ross J; Zummer M; Tucker L; Pineau C; Levy D; Hudson M; Hitchon CA; Huber AM; Smith CD; Avina-Zubieta A; Arbillaga H; Chédeville G; Wynant W; Fortin PR;
J Rheumatol; 2019 Feb; 46(2):166-175. PubMed ID: 30219771
[TBL] [Abstract][Full Text] [Related]
39. Ovarian function and disease activity in patients with systemic lupus erythematosus.
Shabanova SS; Ananieva LP; Alekberova ZS; Guzov II
Clin Exp Rheumatol; 2008; 26(3):436-41. PubMed ID: 18578965
[TBL] [Abstract][Full Text] [Related]
40. Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment.
Ruiz-Limon P; Barbarroja N; Perez-Sanchez C; Aguirre MA; Bertolaccini ML; Khamashta MA; Rodriguez-Ariza A; Almadén Y; Segui P; Khraiwesh H; Gonzalez-Reyes JA; Villalba JM; Collantes-Estevez E; Cuadrado MJ; Lopez-Pedrera C
Ann Rheum Dis; 2015 Jul; 74(7):1450-8. PubMed ID: 24658835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
